Novo Nordisk Recalls Norditropin Pens Due to Delivery System Defect
Novo Nordisk is recalling 723 Norditropin FlexPro pens due to a potential assembly fault that may cause the pen to block during the air shot step.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk-of-harm product (injection device malfunction) where injury has not yet been reported, fitting the 'High' severity criteria.
Plain-English summary
Novo Nordisk Inc. is recalling 723 units of Norditropin (somatropin) FlexPro Prefilled Pens, NDC 0169-7703-21, Lot Number FC70222. The recall is due to a defective delivery system characterized by a low frequency assembly fault. This fault may result in the pen blocking during the "air shot" step of the injection process.
The affected pens were distributed nationwide. Norditropin is a prescription-only medication containing somatropin (rDNA origin) used for subcutaneous injection. The recall is classified as FDA Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients and healthcare providers should stop using the affected pens and contact their healthcare provider or Novo Nordisk for further instructions. Consumers should check their medication packaging for the specific lot number and NDC code to determine if their product is affected.
The recalled product
- Product
- NORDITROPIN (SOMATROPIN)
- Brand
- NORDITROPIN
- Manufacturer
- Novo Nordisk Inc
- Category
- Drug — Prescription Injection
- Affected units
- 723
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Number FC70222
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Novo Nordisk Inc
See all →- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateNovo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same hazard · device malfunction
See all →- HighPhilips Incisive CT Recalled for Potential Failure to Trigger Clinical Scan
FDA (Devices) · 2026-09-02
- HighBD Needle Kit for Powered Driver Recall Due to Removal Difficulty
FDA (Devices) · 2026-08-26
- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighIntegrated Medcraft Recalls First Aid Kits with Defective Airway Tips
FDA (Devices) · 2026-08-12
- SevereStryker AHTO Tube Set Packaging Recalled for Handpiece Leaking
FDA (Devices) · 2026-08-12